Deep Transcranial Magnetic Stimulation in Patients With Opioid Use Disorder: A Double-Blind, Placebo-Controlled Randomized Trial.

Although no statistically significant improvements were observed, the active group showed a trend toward reduced craving and stable buprenorphine‐naloxone doses compared to the sham group.

also in 53,322 other papers

Although the active TMS group exhibited more reduction in craving and a less pronounced increase in buprenorphine‐naloxone dose during the treatment period compared to the sham group, these differences did not reach statistical significance.

also in 111,027 other papers

Among these results, it is seen that the effect sizes show an increasing trend from baseline to the second month for OC‐VAS.

also in 63,971 other papers